Polio outbreak confirmed in Mozambique

Following confirmation of circulating vaccine-derived poliovirus type 2 (cVDPV2) on 8 January 2019, planning for an outbreak response is underway.

Mothers waiting to have their children vaccinated. © WHO AFRO
Mothers waiting to have their children vaccinated. © WHO AFRO

A new circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak has been confirmed in Mozambique. Two genetically-linked circulating vaccine-derived poliovirus type 2 (cVDPV2) isolates were detected from an acute flaccid paralysis (AFP) case (with an onset of paralysis on 21 October 2018, in a six-year old girl with no history of vaccination, from Molumbo district, Zambézia province), and a community contact of the case.

As polio is a highly infectious disease which transmits rapidly, there is potential for the outbreak to spread to other children across the country, or even into neighbouring countries, unless swift action is taken. Global Polio Eradication Initiative and partners are working with country counterparts to support the local public health authorities in conducting a field investigation (clinical, epidemiological and immunological) and thorough risk assessment to discuss planning and implementation of immunization and outbreak response.

In January 2017, a single VDPV2 virus had been isolated from a 5-year old boy with AFP, also from Zambézia province. Outbreak response was conducted in the first half of 2017 with monovalent oral polio vaccine type 2 (mOPV2).

Read our Mozambique country page to see information on cases, surveillance and response to the developing outbreak.

Related resources


Related News

   15/06/2022
Medical doctors and religious teachers play a crucial role in building trust and convincing families to vaccinate their children against polio
   30/05/2022
World Health Assembly challenged to take urgent action before window of opportunity closes to eradicate polio; tackle cVDPVs with same urgency as WPVs
   20/05/2022
The first supplementary polio campaign in eight years puts caregivers to the test
   19/05/2022
Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance
   18/05/2022
18 May 2022